Korean J Endocr Surg.  2010 Dec;10(4):235-239. 10.16956/kjes.2010.10.4.235.

Significance of ¹⁸F FDG PET-CT for Preoperative Diagnosis of Cervical Lymph Nodes Metastasis in Papillary Thyroid Carinoma

• Kim SR
• Kang HJ
• Park KS
• Paik NS
• Yoo YB

• KMID: 2375475
• DOI: http://doi.org/10.16956/kjes.2010.10.4.235

Abstract

PURPOSE
To compare the diagnostic accuracy of US/CT with US/CT/¹â¸F-FDG PET-CT in the diagnosis of cervical lymph nodes metastasis in papillary thyroid carcinoma.
METHODS
From July 2008 to May 2010, 36 patients with papillary thyroid carcinoma, confirmed by aspiration cytology analysis, underwent neck US, neck CT and ¹â¸F-FDG PET-CT preoperatively. The sensitivity, specificity and diagnostic accuracy of the US/CT, US/CT/PET-CT was analyzed according to lymph node level (all: levels I~VI, central: level VI, lateral: levels I~V).
RESULTS
At all lymph nodes group (level I~VI), US/CT/ PET-CT showed a sensitivity of 66.6%, a specificity of 61.9% and a diagnostic accuracy of 63.8%. The corresponding values for US/CT were 60.0%, 85.7%, 75.0% respectively. Considering the central cervical nodes group (level VI), US/CT/PET-CT showed a sensitivity of 57.1%, a specificity of 68.1%, and a diagnostic accuracy of 63.8%. The corresponding values of US/CT were 57.1%, 90.9%, 77.7% respectively. Considering the lateral cervical nodes group (level I~V), US/CT/PET-CT showed a sensitivity of 100%, a specificity of 84.3%, and a diagnostic accuracy of 86.1%. The corresponding values of US/CT were 75.0%, 84.3%, 83.3% respectively. The diagnostic results of US/ CT, US/CT/PET-CT in initial evaluation of the cervical nodes metastasis did not differ significantly.
CONCLUSION
Our preliminary results suggest that additional PET-CT evaluation in US/CT does not provide statistically significant benefit for initial diagnosis of cervical lymph nodes metastasis in papillary thyroid carcinoma.

Keyword

Papillary thyroid carcinoma; Cervical lymph nodes metastasis; ¹⁸F FDG PET-CT

MeSH Terms

Diagnosis*
Humans
Lymph Nodes*
Neck
Neoplasm Metastasis*
Sensitivity and Specificity
Thyroid Gland*
Thyroid Neoplasms

Reference

1.Hundahl SA., Fleming ID., Fremgen AM., Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer. 1998. 83:2638–48.

2.Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993. 328:553–9.

3.Ito Y., Tomoda C., Uruno T., Takamura Y., Miya A., Kobayashi K, et al. Ultra-sonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg. 2005. 29:917–20.

4.Scheumann GF., Gimm O., Wegener G., Hundeshagen H., Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994. 18:559–67.

5.Sellers M., Beenken S., Blankenship A., Soong SJ., Turba-therrera E., Urist M, et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg. 1992. 164:578–81.

6.Kouvaraki MA., Shapiro SE., Fornage BD., Edeiken-Monro BS., Sherman SI., Vassilopoulou-Sellin R, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003. 134:946–54.

7.Stulak JM., Grant CS., Farley DR., Thompson GB., van Heerden JA., Hay ID, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg. 2006. 141:489–94.

8.Senchenkov A., Staren ED. Ultrasound in head and neck surgery: thyroid, parathyroid glands and neck lymph nodes. Surgical Clinics of North America. 2004. 84:973–1000.

9.Solbiati L., Osti V., Cova L., Tonolini M. Ulatrasound of thyroid, parathyroid glands and neck lymph nodes. European Radiology. 2001. 11:2411–24.

10.Kim EH., Park JS., Son KR., Kim JH., Jeon SJ., Na DG. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: Comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid. 2008. 18:411–8.

11.Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol. 1992. 158:961–9.

12.Mitchell JC., Grant F., Evenson AR., Parker JA., Hasselgren PO., Parangi S. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery. 2005. 138:1166–74.

13.Choi WH., Chung YA., Kim KJ., Park CS., Jung HS., Sohn HS, et al. Comparison of FDG uptake with pathological parameters in the well-differentiated thyroid cancer. Nucl Med Mol Imaging. 2009. 43:40–7.

14.Wang W., Macapinlac H., Larson SM., Yeh SD., Akhurst T., Finn RD, et al. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic ¹³¹I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab. 1999. 84:2291–302.

15.Dietlein M., Scheidhauer K., Voth E., Theissen P., Schicha H. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cnacer. Eur J Nucl Med. 1997. 24:1342–8.